Načítá se...
Immune Checkpoint Inhibitor Associated Type 1 Diabetes
Background: Immune-checkpoint inhibitors are increasingly being used in cancer therapy. Nivolumab is a monoclonal antibody that has been used in a variety of conditions such as metastatic melanoma. Treatment with immune checkpoint inhibitors enhances immune response but is also known to diminish imm...
Uloženo v:
| Vydáno v: | J Endocr Soc |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8265934/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.789 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|